FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095587 [Registered on: 03/10/2025] Trial Registered Prospectively
Last Modified On: 03/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Single Arm Study 
Public Title of Study   Saliva and Blood Tests for Gum Disease: Before and After Treatment 
Scientific Title of Study   EVALUATION OF SALIVARY AND SERUM INTERLEUKIN -38 AND THROMBOMODULIN LEVELS IN PERIODONTITIS PATIENTS BEFORE AND AFTER NON-SURGICAL PERIODONTAL THERAPY: A CLINICAL AND BIOCHEMICAL STUDY 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Supriti Brahma 
Designation  Post Graduate  
Affiliation  Department of Periodontology, Room no- 106, SRM Kattankulathur Dental College  
Address  SRM Kattankulathur Dental College SRM Nagar, Kattankulathur Chengalpattu District Tamil Nadu-603203, India
SRM Kattankulathur Dental College SRM Nagar, Kattankulathur Chengalpattu District Tamil Nadu-603203, India
Kancheepuram
TAMIL NADU
603203
India 
Phone  8638863297  
Fax    
Email  drsupritibrahma@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr A.V Saravanan 
Designation  Professor 
Affiliation  Department of Periodontology, Room no- 106, SRM Kattankulathur Dental College  
Address  SRM Kattankulathur Dental College SRM Nagar, Kattankulathur Chengalpattu District Tamil Nadu-603203, India
SRM Kattankulathur Dental College SRM Nagar, Kattankulathur Chengalpattu District Tamil Nadu-603203, India
Kancheepuram
TAMIL NADU
603203
India 
Phone  9944361464  
Fax    
Email  saravana4@srmist.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Supriti Brahma 
Designation  Post Graduate  
Affiliation  Department of Periodontology, Room no.-106, SRM Kattankulathur Dental College  
Address  SRM Kattankulathur Dental College SRM Nagar, Kattankulathur Chengalpattu District Tamil Nadu-603203, India
SRM Kattankulathur Dental College SRM Nagar, Kattankulathur Chengalpattu District Tamil Nadu-603203, India
Kancheepuram
TAMIL NADU
603203
India 
Phone  8638863297  
Fax    
Email  drsupritibrahma@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Supriti Brahma 
Address  SRM Kattankulathur Dental College SRM Nagar, Kattankulathur Chengalpattu District Tamil Nadu-603203, India 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Supriti Brahma  SRM Kattankulthaur Dental College and Hospital  Department of Periodontology Room no- 106 SRM Kattankulathur Dental College SRM Nagar, Kattankulathur Chengalpattu District Tamil Nadu-603203, India SRM Kattankulathur Dental College SRM Nagar, Kattankulathur Chengalpattu District Tamil Nadu-603203, India
Kancheepuram
TAMIL NADU 
08638863297

drsupritibrahma@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRM MEDICAL COLLEGE HOSPITAL & RESEARCH CENTRE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Non-Surgical Periodontal Therapy  All participants will receive non-surgical periodontal therapy (scaling and root planing) with oral hygiene instructions. Saliva and blood samples will be collected at baseline and follow-up (1 months) to measure interleukin-38 and thrombomodulin using ELISA. Clinical periodontal parameters will also be recorded before and after therapy. 
Comparator Agent  Not applicable   Not applicable  
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Age- 21 to 60 years of age
Both males and females 
 
ExclusionCriteria 
Details  1. Individuals with systemic illness
2. Pregnant & lactating women
3. History of medications such as antibiotics or anticoagulant therapy for past 6 months
4. Participants with previous periodontal treatment or periodontal surgery for past 6 months
5. Smokers 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Change in IL-38 and thrombomodulin concentrations (saliva and serum) — measured by ELISA.  Change in IL-38 and thrombomodulin concentrations (saliva and serum) — measured by ELISA.At baseline and 4 weeks after treatmnet 
 
Secondary Outcome  
Outcome  TimePoints 
Clinical periodontal parameters (measured by calibrated examiner):
Mean probing depth (PD), mean clinical attachment level (CAL), and bleeding on probing (BOP %). 
Time points: Baseline (T0) and 3 months (T1). 
 
Target Sample Size   Total Sample Size="49"
Sample Size from India="49" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Aim of the study is to evaluate the salivary and serum levels of Interleukin-38 (IL-38) and Thrombomodulin (TM) in patients with periodontitis before and after non-surgical periodontal therapy (NSPT). IL-38, a recently identified anti-inflammatory cytokine, and TM, an endothelial glycoprotein with anticoagulant activity, may play significant roles in periodontal inflammation and healing. By assessing 49 patients with Stage II periodontitis, clinical parameters such as plaque index, gingival bleeding index, probing depth, and attachment level, along with biochemical analysis of IL-38 and TM using ELISA, will be compared pre- and post-therapy. The study seeks to determine whether changes in these biomarkers reflect treatment outcomes, potentially establishing them as novel indicators for monitoring disease activity and therapeutic response in periodontitis. 
Close